Outcomes for the extremely premature infant: what is new? And where are we going?
about
Caffeine therapy in preterm infantsFactors associated with neonatal intensive care follow-up appointment compliance.Apnea of prematurity: from cause to treatmentPerinatal factors associated with early neonatal deaths in very low birth weight preterm infants in Northeast Brazil.Neuromodulation of Limb Proprioceptive Afferents Decreases Apnea of Prematurity and Accompanying Intermittent Hypoxia and Bradycardia.Language at rest: A longitudinal study of intrinsic functional connectivity in preterm children.Cerebral palsy among term and postterm births.Maternal Education Level Predicts Cognitive, Language, and Motor Outcome in Preterm Infants in the Second Year of Life.Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment conceptsEffect of Early Physical Activity Programs on Motor Performance and Neuromuscular Development in Infants Born Preterm: A Randomized Clinical Trial.Brain visual impairment in childhood: mini review.A population-based study and systematic review of hearing loss in children with cerebral palsy.Accounting for deaths in neonatal trials: is there a correct approach?High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.Continuity and coordination of care during and after neonatal intensive care.Effect of caffeine on preterm infants' cerebral cortical activity: an observational study.Motion Perception and Form Discrimination in Extremely Preterm School-Aged Children.fMRI: blood oxygen level-dependent activation during a working memory-selective attention task in children born extremely preterm.Reliability, sensitivity and responsiveness of the Infant Behavioral Assessment in very preterm infants.
P2860
Q26777204-7443BEF9-D281-4CE2-84F0-52F7626D1FD6Q30456487-7B74DDE2-7BF7-4DAB-9B4D-623B4AFAD1B7Q34163237-3D962A45-A0AE-4F75-9621-406005AD9BFAQ35021342-C49869EB-4DBA-4425-B2F4-E4E2623996DCQ36053124-C69FDDA6-4E10-4D7E-823C-C80D3D53320DQ36580650-B64765D3-4270-4DED-8001-673D006F4E1EQ37013404-D7C51426-F679-4FC5-94DB-31606CA5AFA1Q37033752-56B20268-14FE-4ECC-8868-E3FEF16985C8Q37347049-875E0DFD-3CDB-429B-A7CA-CA9A5733A762Q37697632-B57E3CE5-9C0F-42F4-ABB0-D75371DD8FBFQ37839737-7E768E59-906F-4AE1-A490-7378BB9BC190Q37927131-AD661F75-A429-44AF-8731-79A09291D92BQ38326179-A3496F60-91BC-4D1D-9E78-4159C6D5AEF1Q39259244-6CC73B5D-AE0C-4EFA-8199-2D16E7853B7CQ43821402-B0EA9B3F-983E-4F69-97EB-C568BCA1F75BQ46683333-C7C69D45-0E0F-406D-99A5-7AF292E2FD50Q47290075-07B92703-A8E4-4141-B44A-ADCEEDFADABDQ50735905-053C25D0-D7EE-4B2D-B7A2-12AE0BA3079BQ51851474-38167571-CDB8-47D4-8F6D-82C8E2220CBD
P2860
Outcomes for the extremely premature infant: what is new? And where are we going?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Outcomes for the extremely premature infant: what is new? And where are we going?
@en
Outcomes for the extremely premature infant: what is new? And where are we going?
@nl
type
label
Outcomes for the extremely premature infant: what is new? And where are we going?
@en
Outcomes for the extremely premature infant: what is new? And where are we going?
@nl
prefLabel
Outcomes for the extremely premature infant: what is new? And where are we going?
@en
Outcomes for the extremely premature infant: what is new? And where are we going?
@nl
P2093
P1433
P1476
Outcomes for the extremely premature infant: what is new? And where are we going?
@en
P2093
Charlene M T Robertson
Irina A Dinu
Man-Joe Watt
P304
P356
10.1016/J.PEDIATRNEUROL.2008.09.017
P577
2009-03-01T00:00:00Z